Skip to main content
. Author manuscript; available in PMC: 2010 Mar 15.
Published in final edited form as: Clin Infect Dis. 2009 Mar 15;48(6):739–744. doi: 10.1086/597037

Table 1.

Patient characteristics of CMY- and ESBL-producing E. coli cases. Number or proportion (%) of cases is shown unless specified otherwise.

Characteristic CMY cohort ESBL cohort P value
Mean age (SD) 62.0 (21.0) 62.4 (20.0) 0.97
Female 18/22 (82) 19/25 (76) 0.63
Caucasian 20/21 (95) 18/23 (78) 0.10
Transfer from another hospital 3/22 (14) 0/25 (0) 0.056
Previous hospitalization within 3 months 11/21 (52) 14/25 (56) 0.81
Previous location within 30 days
  Home 12/20 (60) 13/24 (54) 0.70
  Nursing home/LTCF 5/20 (25) 7/24 (29) 0.76
  Hospital 2/20 (10) 4/24 (17) 0.52
Site of acquisition
  Hospital-acquired 11/21 (52) 7/25 (28) 0.091
  Healthcare-associated 7/21 (33) 14/25 (56) 0.12
  Community-associated 3/21 (14) 3/25 (12) 0.82
Chronic underlying diseases 19/21 (90) 23/25 (92) 0.86
Immunosuppression 13/21 (62) 16/25 (64) 0.88
Previous antibiotic use within 30 days 8/21 (38) 9/25 (36) 0.88
Site of infection/colonization
  Urinary tract 17/22 (77) 18/25 (72) 0.68
Symptomatic infection 15/19 (79) 10/22 (45) 0.028

NOTE. LTCF; long-term care facility.